2,239 press releases in English indexed under biotech & pharma.
Panel on chronic conditions and off-target effects of vaccines, and a presentation on Pinion's EBV immunotherapeutic program ROCKVILLE, Md., October 19, 2026--Pinion Immunotherapeutics, a clinical-stage biotechnology company developing AI-designed mRNA immunotherapeutics for latent viral infections and
MENLO PARK, Calif., October 19, 2026--Hippocratic AI today announced seven senior executive appointments spanning operations, legal, government solutions, pharma, global partnerships, marketing, and finance. The hires follow the company's August 13 launch of Agentic Orchestrators — teams of conversatio
FDA Clearance of Investigational New Drug Application for PVT201, in development for the treatment of autoimmune liver disease and prevention of organ transplant rejection, is the first candidate from the Parvus nanomedicine immune tolerance platform to clear an IND. [PR.com]
PALO ALTO, Calif., Oct. 19, 2026 -- Riboscience, a clinical-stage biotechnology company developing first-in-class immunotherapies, today announced that Phase 1b data for RBS2418, its lead oral ENPP1 inhibitor, will be presented in a poster at the European Society for Medical...
Sanofi S.A. has earned ISPE's top FOYA honor for excellence and innovation in pharmaceutical facility design and manufacturing. NORTH BETHESDA, Md., Oct. 19, 2026 -- The International Society for Pharmaceutical Engineering (ISPE) has recognized Sanofi S.A. as the FOYA Overall...
WILMINGTON, Del., October 19, 2026--Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place Oc
King of Prussia, Pennsylvania--(October 19, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA therapeutic platform, including its lead clinical candidate PH-762 for the treatment of...
GENEVA, SWITZERLAND and HYDERABAD, INDIA - October 19, 2026 - Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, today announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory based in Hyderabad, India. The acquisition strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors. Serving customers across India, the United States, Asia-Pacific, and the Middle East, Energon is recognized for its scientific excellence, regulatory expertise and commitment to quality. Strategically located in Hyderabad, one of the world's leading pharmaceutical and biotechnology hubs, Energon provides Cotecna with access to highly specialized scientific talent, advanced laboratory infrastructure and a well-established pharmaceutical ecosystem. India is also one of the world's fastest-growing pharmaceutical markets and a critical manufacturing hub for global healthcare supply chains. The acquisition enhances the Cotecna's ability to support both Indian and international customers with high-quality, regulatory-compliant testing services while delivering greater responsiveness, scalability and operational efficiency across key markets. The addition of Energon further complements Cotecna's growing pharmaceutical testing network which includes Cotecna Life Sciences, Shiva Analyticals and Neotron Pharma. Together, this capabilities strengthen the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance and regulatory requirements. Energon offers a comprehensive portfolio of analytical testing and quality assurance services, including analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptides and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services. These capabilities will further strengthen Cotecna's position as a trusted partner to pharmaceutical manufacturers serving regulated markets worldwide. Sebastien Dannaud, Chief Executive Officer of Cotecna Group, commented: “We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India, and strengthens our position in one of the world's most important pharmaceutical markets.” Amit Chopra, CEO South Asia and Middle East, Cotecna Group, added: "I am delighted to welcome Manikanth Reddy and the talented team of Energon Labs to the Cotecna group. This acquisition aligns perfectly with our strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets. Energon's strong technical capabilities, experienced team and established customer relationships will enhance our ability to serve pharmaceutical, biopharmaceutical and medical device companies across India and globally. Together, we are creating a stronger platform to support the evolving needs of the pharmaceutical and healthcare sectors. " Manikanth Reddy, Founder, Energon, said: "Joining the Cotecna Group opens an exciting new chapter for Energon Labs. Over the years, we have focused on building a laboratory recognized for quality, scientific expertise and reliability. Becoming part of a global organization like Cotecna provides new opportunities to expand our capabilities, strengthen our service offerings and deliver even greater value to our customers. Our team remains committed to maintaining the highest standards of analytical excellence while supporting the continued growth of the life sciences industry.” About Energon Labs Energon Labs is a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory located in Hyderabad, India. The company provides comprehensive analytical testing, quality assurance and regulatory support services to pharmaceutical, biopharmaceutical, medical device and packaging industries, serving customers across India, the United States, Asia Pacific and the Middle East. About Cotecna Founded in Switzerland in 1974, Cotecna is a leading provider of Testing, Inspection and Certification services. With operations in more than 55 countries, Cotecna helps clients ensure quality, safety, compliance and sustainability across global supply chains. The Group serves customers across agriculture and food, pharmaceuticals, minerals and metals, consumer products, certification and ESG services through a worldwide network of experts, laboratories and technical specialists.
Inside Information
African Export-Import Bank (Afreximbank) (www.Afreximbank.com), in partnership with the African Association of Automotive Manufacturers (AAAM), the African Continental Free Trade Area (AfCFTA) Secretariat, the Ministry of Trade and Investment of Egypt, and the Department of Trade and Industry of South Africa, hosted the Africa Automotive Investment Forum on the sidelines of the Alamein Africa Forum held in El Alamein, Egypt recently. The two-day Forum brought together high-level African automotive industry policymakers, private sector original equipment manufacturers (OEMs) and Africa-based component manufacturers. The Forum sought to sensitise policymakers on the policy changes and reforms needed to develop the automotive sector, enable investors to engage directly with both policymakers and manufacturers, and facilitate potential joint ventures and supply agreements or engagements leading to future deals. Afreximbank noted that the Forum prioritised joint ventures and technology transfer agreements between global auto giants and African enterprises with the expectation of creating highly skilled engineering, manufacturing and technical jobs for Africa's growing youth demographic while significantly boosting local small and medium enterprises within the secondary supply tier. It described the automotive sector as a strategic priority because it serves as a powerful catalyst for Africa’s industrialisation, intra-African trade and economic resilience, noting that several African countries were already making important strides in the development of a manufacturing sector that had attracted increasing investment into the emerging auto industry, including new energy vehicles. Highlighting the significance of the Forum for Afreximbank, Mrs. Kanayo Awani, Executive Vice President, Intra-African Trade and Export Development, said: “The automotive sector is a critical pillar for advancing Africa’s industrialisation and achieving the structural transformation championed by Afreximbank. By driving regional value chain integration, the automotive industry directly aligns with our mandate to foster intra-African trade under the AfCFTA framework. Supporting this sector allows Afreximbank to catalyse high-impact investments, stimulate manufacturing capabilities, create skilled employment, and significantly reduce the continent's heavy reliance on vehicle imports. Investing in the African automotive ecosystem is not merely a financing opportunity, but a strategic imperative that accelerates economic diversification and establishes Africa as a competitive player in the global industrial economy.” Mrs. Awani said that significant investment opportunities existed in Africa’s automotive manufacturing sector, including component manufacturing, leveraging the continent’s growing skills base and raw materials such as lithium, cobalt, manganese, nickel, copper, iron and steel. She added that Afreximbank was championing the development of a pan-African automotive manufacturing sector comprising an interrelated component and vehicle manufacturing ecosystem, supported by intra-African supply chains and trade. Mrs. Awani noted that Afreximbank had committed US$1 billion towards financing Africa’s automotive sector as part of its strategy to promote manufacturing, trade and industrial development across Africa. The Forum witnessed the signing of a joint venture agreement between Malben Engineering from South Africa and Egypt-based industrial conglomerate El Araby Group to establish a joint platform for manufacturing components serving Egyptian, South African and broader African markets. The undertaking combines El Araby Group’s industrial, engineering, and technological capabilities with Malben Engineering’s experience spanning over 50 years in manufacturing and forming metal automotive components. The joint venture illustrates the type of commercial partnership that will spur development of intra-African automotive supply chains and trade. Mr. Tarek Mosaad, President of the African Association of Automotive Manufacturers (AAAM) said: “with the AfCFTA Rules of Origin now agreed, the foundation for a more integrated automotive industry is in place. Our focus must shift to turning ambition into action by creating factories, strengthening supplier ecosystems, generating jobs, and increasing intra-African trade.” He noted that “AAAM remains focused on three key priorities: Growing local content through regional value chains Making it easier to move automotive products across borders Ensuring Africa plays a meaningful role in shaping the future of mobility| In his call to action, he cautioned that “investors are not looking at 54 separate African markets. They are looking at one integrated opportunity.” H.E. Wamkele Mene, Secretary-General of the AfCFTA Secretariat, echoed the sentiments expressed by Afreximbank and AAAM and outlined three priorities for advancing the Strategy for the African Automotive Sector under the AfCFTA framework, namely: “developing investment-ready projects and competitive production locations; strengthening regional supplier networks and deepening localisation; and establishing commercially viable regional production.” In a further step towards advancing these priorities, the AfCFTA Secretariat and the African Association of Automotive Manufacturers (AAAM) signed a Memorandum of Understanding (MoU) to strengthen cooperation in developing Africa's automotive industry. The MoU provides a framework for cooperation in implementing the Strategy for the African Automotive Sector under the AfCFTA, covering automotive Rules of Origin, customs procedures and trade facilitation, automotive policy and standards, capacity building, regional supplier and value-chain development, mineral beneficiation, investment mobilisation and emerging automotive technologies. The partnership will also support ongoing efforts by the AfCFTA Secretariat and Afreximbank to advance the AfCFTA Automotive Investment Plan, with a focus on mobilising investment and strengthening competitive regional automotive production networks. The Forum also witnessed the establishment of a joint Egypt-South Africa Business Council designed to develop bilateral trade and investment projects across various priority sectors that include automotive, mining and mineral resources, renewable energy, agriculture and food production, pharmaceuticals, transport and logistics infrastructure – leveraging the Suez Canal and national ports in both countries to facilitate increased trade between northern and southern Africa. For a more practical experience, delegates moved from policy discussion to industry exposure through curated site visits to OEMs Nissan Motor Corporation, General Motors Egypt, Al Mansour Automotive and components manufacturer Mobica in 6th of October City. The visits offered a first-hand view of Egypt’s automotive industrial base, showcasing the progression from vehicle assembly and localisation to supplier development, manufacturing capabilities and regional market reach, while illustrating the tangible opportunities for investment, technology transfer and cross-border value-chain integration that can help position Africa as a competitive automotive manufacturing hub. With African vehicle demand expected to reach 5 million by 2035 as well as rising interest in new energy vehicles globally, industry stakeholders and policymakers are seeing opportunities to drive domestic industrialisation through the automotive sector and renewables, leveraging African raw materials. Forum participants emphasised that the policy incentives must be right and that the provision of affordable financing will help drive demand and capital investments. Distributed by APO Group on behalf of Afreximbank. Media Contact: Vincent Musumba press@afreximbank.com Alexandre Siewe Alexandre.Siewe@au-afcfta.org AAAM coms@aaamafrica.com Follow Afreximbank on: https://apo-opa.co/3Wj3OCh https://apo-opa.co/4i4FpHR https://apo-opa.co/4seRkHO https://apo-opa.co/47scZmq About Afreximbank: For more information, visit: www.Afreximbank.com About AfCFTA: For more information, visit: AU-AfCFTA.org About AAAM: AAAM’s mission is to create sustainable and affordable mobility solutions, facilitate strategic linkages and partnerships, and develop regional automotive value chains that promote production and trade within and beyond the African Continental Free Trade Area (AfCFTA). AAAM is also committed to championing access to affordable financing for both the automotive industry and consumers. Today, AAAM proudly represents a network of more than 70 members spanning the continent, working together to shape Africa’s automotive future. For more information visit https://AAAMAfrica.com/
SUNNYVALE, Calif., Oct. 19, 2026 -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its pre-submission package for marketing clearance of its Helix catheter (“Helix”) intended for therapeutic and diagnostic agent delivery.
Personalized outreach across five vaccine types cut unsubscribe rates 62%, with nearly half of vaccinated patients acting after just two nudges KNOXVILLE, Tenn., October 19, 2026--Lirio , the first-ever behavioral science and AI-powered behavioral intelligence platform that empowers people to live the